Physician profile
Brett Matthew Baker
NPI 1861458853
$84,974.69
in general payments reported to CMS, 2019-2025
32 companies · $34K in 2025
The $34K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $609 · 2021: $2,523 · 2022: $4,955 · 2023: $3,875 · 2024: $21K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $22K · Food and Beverage: $6,465 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,200.00 |
| Travel and Lodging | $22,163.46 |
| Food and Beverage | $6,464.78 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $53,790.74 | 2021-2025 | Affera Mapping System, Arctic Front Advance, Pulseselect |
| Pfizer INC. | $11,811.12 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $8,740.30 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $2,315.69 | 2019-2025 | Ensite Precision, Amplatzer Amulet, Tacticath Ablation Catheter, Sensor Enabled |
| Biotronik INC. | $2,181.89 | 2019-2025 | Acticor 7 Vr-T Dx, Selectra, Rivacor 7 Dr-T |
| Boston Scientific Corporation | $1,736.34 | 2019-2025 | Watchman Access System, Resonate El Icd Vr, Farapulse |
| Cms Imaging, INC. | $766.87 | 2022-2025 | |
| Atricure, INC. | $561.26 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $557.06 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $455.71 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $319.05 | 2019-2022 | |
| Philips North America LLC | $312.40 | 2024 | (Cm9) Amb Mon & Diag Und |
| Siemens Medical Solutions USA, INC. | $225.76 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $214.55 | 2019-2023 | Uptravi, Opsumit |
| Vital Connect, INC | $168.97 | 2023-2025 | Vitalpatch Rtm |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $158.59 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $134.71 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.83 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $75.28 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $73.17 | 2021-2023 | Verquvo |
| Novo Nordisk INC | $42.75 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Becton, Dickinson and Company | $42.20 | 2025 | Hemosphere |
| Altathera Pharmaceuticals LLC | $28.66 | 2021 | |
| Edwards Lifesciences Corporation | $20.60 | 2024 | Hemosphere |
| Cardiva Medical, INC. | $20.42 | 2022 | |
| Xeris Pharmaceuticals, INC. | $20.32 | 2023 | Keveyis |
| Cvrx, INC. | $19.50 | 2024 | Barostim Neo System |
| Bardy Diagnostics, INC. | $18.00 | 2019-2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $17.04 | 2023 | Arcalyst |
| Cardinal Health 200 LLC | $15.97 | 2019 | |
| Esperion Therapeutics, INC. | $15.04 | 2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $13.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.